Johnson & Johnson (JNJ) Payables (2009 - 2026)
Johnson & Johnson recorded quarterly Payables of $27.9 billion in Q1 2026, up 36.29% quarter-over-quarter from $20.5 billion in Q4 2025, and up 19.1% year-over-year from $23.4 billion in Q1 2025.
Johnson & Johnson's Payables history runs 18 years deep, the most recent figure standing at $27.9 billion for Q1 2026.
- In Q1 2026, Payables rose 19.1% year-over-year to $27.9 billion; the TTM figure through Mar 2026 stood at $27.9 billion (up 19.1% YoY), while the FY2025 annual figure was $20.5 billion, up 25.73% from the prior year.
- Payables came in at $27.9 billion for Q1 2026 at Johnson & Johnson, up from $20.5 billion in the prior quarter.
- In the past five years, Payables ranged from a high of $27.9 billion in Q1 2026 to a low of $12.2 billion in Q4 2023.
- A 5-year average of $18.3 billion and a median of $16.5 billion in 2024 frame the typical range for Payables.
- On a YoY basis, Payables climbed as much as 104.97% in 2023 and fell as far as 42.23% in 2023.
- Johnson & Johnson's Payables stood at $14.6 billion in 2022, then decreased by 10.25% to $13.1 billion in 2023, then increased by 24.54% to $16.3 billion in 2024, then rose by 25.73% to $20.5 billion in 2025, then surged by 36.29% to $27.9 billion in 2026.
- According to Business Quant data, Payables over the past three periods registered $27.9 billion, $20.5 billion, and $16.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.03 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 27.92 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 33.77 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 6.01 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.94 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 645.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 4.51 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 4.23 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 24.45 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 27.92 Bn |
| Dec 28, 2025 | 20.49 Bn |
| Sep 28, 2025 | 16.01 Bn |
| Jun 29, 2025 | 20.99 Bn |
| Mar 30, 2025 | 23.44 Bn |
| Dec 29, 2024 | 16.29 Bn |
| Sep 29, 2024 | 13.42 Bn |
| Jun 30, 2024 | 18.70 Bn |
| Mar 31, 2024 | 16.72 Bn |
| Dec 31, 2023 | 13.08 Bn |
| Oct 1, 2023 | 12.23 Bn |
| Jul 2, 2023 | 22.14 Bn |
| Apr 2, 2023 | 27.89 Bn |
| Jan 1, 2023 | 22.65 Bn |
| Oct 2, 2022 | 14.58 Bn |
| Jul 3, 2022 | 14.07 Bn |
| Apr 3, 2022 | 13.61 Bn |
| Jan 2, 2022 | 14.82 Bn |
| Oct 3, 2021 | 12.76 Bn |
| Jul 4, 2021 | 11.88 Bn |
| Apr 4, 2021 | 11.85 Bn |
| Jan 3, 2021 | 12.14 Bn |
| Sep 27, 2020 | 12.12 Bn |
| Jun 28, 2020 | 12.10 Bn |
| Mar 29, 2020 | 9.60 Bn |
| Dec 29, 2019 | 9.75 Bn |
| Sep 29, 2019 | 9.79 Bn |
| Jun 30, 2019 | 8.63 Bn |
| Mar 31, 2019 | 8.63 Bn |
| Dec 30, 2018 | 10.33 Bn |
| Sep 30, 2018 | 8.77 Bn |
| Jul 1, 2018 | 9.19 Bn |
| Apr 1, 2018 | 9.14 Bn |
| Dec 31, 2017 | 11.22 Bn |
| Oct 1, 2017 | 14.88 Bn |
| Jul 2, 2017 | 13.34 Bn |
| Apr 2, 2017 | 11.44 Bn |
| Jan 1, 2017 | 11.60 Bn |
| Oct 2, 2016 | 9.41 Bn |
| Jul 3, 2016 | 7.77 Bn |
| Apr 3, 2016 | 9.08 Bn |
| Jan 3, 2016 | 13.67 Bn |
| Sep 27, 2015 | 11.61 Bn |
| Jun 28, 2015 | 11.36 Bn |
| Mar 29, 2015 | 10.76 Bn |
| Dec 28, 2014 | 11.27 Bn |
| Sep 28, 2014 | 8.72 Bn |
| Jun 29, 2014 | 10.01 Bn |
| Mar 30, 2014 | 10.06 Bn |
| Dec 29, 2013 | 11.12 Bn |
| Sep 29, 2013 | 11.41 Bn |
| Jun 30, 2013 | 11.03 Bn |
| Mar 31, 2013 | 9.90 Bn |
| Dec 30, 2012 | 10.51 Bn |
| Sep 30, 2012 | 10.77 Bn |
| Jul 1, 2012 | 11.19 Bn |
| Apr 1, 2012 | 11.52 Bn |
| Jan 1, 2012 | 12.38 Bn |
| Oct 2, 2011 | 11.06 Bn |
| Jul 3, 2011 | 10.74 Bn |
| Apr 3, 2011 | 14.28 Bn |
| Jan 2, 2011 | 13.24 Bn |
| Oct 3, 2010 | 8.32 Bn |
| Jul 4, 2010 | 8.59 Bn |
| Apr 4, 2010 | 9.17 Bn |
| Jan 3, 2010 | 11.86 Bn |
| Sep 27, 2009 | 9.76 Bn |
| Jun 28, 2009 | 11.27 Bn |